Corrections and Research Notes

Editorial correspondence

Freebase Peptides is glad to hear about anything that sharpens the record: a citation quoted inaccurately, a regulatory status that has shifted, or a peer-reviewed study about retatrutide, MOTS-c, or tesamorelin that belongs on the references page. Corrections that improve the notebook's accuracy are the most useful mail it gets.

The most actionable notes name three things: the page they refer to, the exact passage in question, and the supporting citation — a DOI or PubMed ID wherever possible — so a proposed change can be checked against its source quickly.

Editorial mailbox: editors@freebasepeptides.com

What this desk cannot do

Some things sit outside what a notebook can do. Freebase Peptides is a reading of the literature, not a clinic and not a vendor, so it cannot weigh in on human use of any peptide covered here, cannot suggest a dose, schedule, or route for an individual, and cannot diagnose a condition or judge whether a given finding applies to a particular person. It also cannot sell, source, or help locate any compound from any supplier, and it cannot advise athletes bound by anti-doping rules on using these peptides — several are prohibited in sport.

Anyone seeking medical guidance should consult a licensed clinician in their own jurisdiction. Replies to correspondence are not guaranteed and may be delayed; the mailbox is checked intermittently.